Sheba researcher: Antiparasitic drug ivermectin reduces length of COVID-19 infection

Share it with your friends Like

Thanks! Share it with your friends!

Close

An Israeli tropical-disease expert says he has new proof that a drug used to fight parasites in third-world countries could help reduce the length of infection for people who contract coronavirus. Prof. Eli Schwartz, founder of the Center for Travel Medicine and Tropical Disease at Sheba Medical Center in Tel Hashomer, last week completed a clinical trial of the US Food and Drug Administration-approved drug ivermectin, a broad-spectrum antiparasitic agent that has also been shown to fight viruses. The double-blind, placebo-controlled study included 100 people with mild to moderate cases of the disease who were not hospitalized for the virus. …read more

Source: Sott health news feed

    

  • Rating:
  • Views:57 views
  • Categories: Health